PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Salk scientists uncover new clues to repairing an injured spinal cord

Scientists hope to borrow strategy from simpler animals to repair damaged spinal cord nerves in humans

Salk scientists uncover new clues to repairing an injured spinal cord
2014-08-05
(Press-News.org) LA JOLLA—Frogs, dogs, whales, snails can all do it, but humans and primates can't. Regrow nerves after an injury, that is—while many animals have this ability, humans don't. But new research from the Salk Institute suggests that a small molecule may be able to convince damaged nerves to grow and effectively rewire circuits. Such a feat could eventually lead to therapies for the thousands of Americans with severe spinal cord injuries and paralysis.

"This research implies that we might be able to mimic neuronal repair processes that occur naturally in lower animals, which would be very exciting," says the study's senior author and Salk professor Kuo-Fen Lee. The results were published in PLOS Biology.

For a damaged nerve to regain function, its long, signal-transmitting extensions known as axons need to grow and establish new connections to other cells.

In a study published last summer in PLOS ONE, Lee and his colleagues found that the protein p45 promotes nerve regeneration by preventing the axon sheath (known as myelin) from inhibiting regrowth. However, humans, primates and some other more advanced vertebrates don't have p45. Instead, the researchers discovered a different protein, p75, that binds to the axon's myelin when nerve damage occurs in these animals. Instead of promoting nerve regeneration, p75 actually halts growth in damaged nerves.

"We don't know why this nerve regeneration doesn't occur in humans. We can speculate that the brain has so many neural connections that this regeneration is not absolutely necessary," Lee says.

In the new study, the scientists looked at how two p75 proteins bind together and form a pair that latches onto the inhibitors released from damaged myelin.

By studying the configurations of the proteins in solutions using nuclear magnetic resonance (NMR) technology, the researchers found that the growth-promoting p45 could disrupt the p75 pairing.

"For reasons that are not understood, when p45 comes in, it breaks the pair apart," says Lee, holder of the Helen McLoraine Chair in Molecular Neurobiology.

What's more, the p45 protein was able to bind to the specific region in the p75 protein that is critical for the formation of the p75 pair, thus decreasing the amount of p75 pairs that bond to inhibitors release from myelin. With less p75 pairs available to bond to inhibitor signals, axons were able to regrow.

The findings suggest that an agent—either p45 or another disrupting molecule—that can effectively break the p75 pair could offer a possible therapy for spinal cord damage. One method of therapy could be to introduce more p45 protein to injured neurons, but a smarter tactic might be to introduce a small molecule that jams the link between the two p75 proteins, Lee says. "Such an agent could possibly get through the blood-brain barrier and to the site of spinal cord injuries," he says.

The next step will be to see if introducing p45 helps regenerate damaged human nerves. "That is what we hope to do in the future," Lee says.

INFORMATION: Collaborating with Lee on this work were Tsung-Chang Sung, Zhijiang Chen and Jiqing Xu, from the Salk Institute; Marçal Vilar, Irmina Garcia-Carpio and Eva M. Fernandez, from the Neurodegeneration Unit, UFIEC-ISCIII, in Madrid, Spain; and Rolan Reik from the Laboratory for Physical Chemistry, ETH Zürich, in Zürich, Switzerland.

This research was supported by grants from the National Institutes for Health, Muscular Dystrophy Association and Clayton Foundation.

About the Salk Institute for Biological Studies: The Salk Institute for Biological Studies is one of the world's preeminent basic research institutions, where internationally renowned faculty probe fundamental life science questions in a unique, collaborative, and creative environment. Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer's, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology, and related disciplines.

Faculty achievements have been recognized with numerous honors, including Nobel Prizes and memberships in the National Academy of Sciences. Founded in 1960 by polio vaccine pioneer Jonas Salk, MD, the Institute is an independent nonprofit organization and architectural landmark.

[Attachments] See images for this press release:
Salk scientists uncover new clues to repairing an injured spinal cord

ELSE PRESS RELEASES FROM THIS DATE:

Year-round preventive treatment reduces malaria risk in young children

2014-08-05
A year-round preventive drug treatment substantially reduces young children's risk of contracting malaria and poses no serious risk of adverse events, according to a study by researchers funded by the National Institutes of Health. The findings demonstrate that prolonged treatment given from 6 to 24 months of age is safe and effective for young children, according to the study authors. Year-round preventive measures are badly needed in locations like Uganda, where the study took place, and where malaria rates remain high throughout the year. Most previous studies using ...

How spiders spin silk

2014-08-05
Spider silk is an impressive material; lightweight and stretchy yet stronger than steel. But the challenge that spiders face to produce this substance is even more formidable. Silk proteins, called spidroins, must convert from a soluble form to solid fibers at ambient temperatures, with water as a solvent, and at high speed. How do spiders achieve this astounding feat? In new research publishing in the open access journal PLOS Biology on August 5, Anna Rising and Jan Johansson show how the silk formation process is regulated. The work was done at the Swedish University ...

In search for Alzheimer's drug, a major STEP forward

2014-08-05
Researchers at Yale School of Medicine have discovered a new drug compound that may help reverse the cognitive deficits of Alzheimer's disease. Their findings are publishing on August 5 in the open access journal PLOS Biology. The compound, TC-2153, inhibits the negative effects of a protein called STriatal-Enriched tyrosine Phosphatase (STEP), which is key to regulating learning and memory. These cognitive functions are impaired in Alzheimer's. "Decreasing STEP levels reversed the effects of Alzheimer's disease in mice," said lead author Paul Lombroso, M.D., professor ...

Pyruvate oxidation is critical determinant of pancreatic islet number and β-cell mass

2014-08-05
Researchers at the University at Buffalo, led by Dr. Mulchand Patel and also at Lawson Health Research Institute and Western Ontario, London, Canada, led by Dr. David Hill, collaboratively evaluated the role of the mitochondrial multienzyme pyruvate dehydrogenase complex in the regulation of pancreatic β-cell development and maturation in the immediate postnatal period in mice. This study, reported in the August 2014 issue of Experimental Biology and Medicine, demonstrated that the pyruvate dehydrogenase complex is not only required for insulin gene expression and ...

Butterflies change wing color in new Yale research

Butterflies change wing color in new Yale research
2014-08-05
Yale University scientists have chosen the most fleeting of mediums for their groundbreaking work on biomimicry: They've changed the color of butterfly wings. In so doing, they produced the first structural color change in an animal by influencing evolution. The discovery may have implications for physicists and engineers trying to use evolutionary principles in the design of new materials and devices. The research appears this week in the journal Proceedings of the National Academy of Sciences. "What we did was to imagine a new target color for the wings of a butterfly, ...

Seamless gene correction of beta-thalassemia mutations in patient-specific cells

Seamless gene correction of beta-thalassemia mutations in patient-specific cells
2014-08-05
August 5, 2014 – A major hurdle in gene therapy is the efficient integration of a corrected gene into a patient's genome without mutating off-target sites. In a paper published today in Genome Research, scientists have used CRISPR/Cas genome editing technology to seamlessly and efficiently correct disease-causing mutations in cells from patients with β-thalassemia. β-thalassemia results from inherited DNA mutations in the hemoglobin beta (HBB) gene, resulting in reduced HBB expression in red blood cells and, in the most severe forms, anemia. The only established ...

NASA sees Tropical Storm Julio as part of a heated Eastern Pacific

NASA sees Tropical Storm Julio as part of a heated Eastern Pacific
2014-08-05
The Eastern Pacific Ocean has been warm this springtime, and those warmer waters have contributed to the development of storms like Tropical Storm Julio and Hurricane Iselle. "Ocean temperatures in the Eastern Tropical Pacific were heated up because of the strong Kelvin wave activity this spring. Although the initial excitement of an impending El Nino has quieted down, these warmer waters have caused an early and active hurricane season," said Bill Patzert, Climatologist at NASA's Jet Propulsion Laboratory in Pasadena, California. "Kelvin waves" are massive ripples ...

Grizzly research offers surprising insights into diabetes-obesity link

Grizzly research offers surprising insights into diabetes-obesity link
2014-08-05
While diabetes rates are on the rise and are having serious effects on millions of people's health, researchers studying grizzly bears have now discovered a natural state of diabetes that serves a real biological purpose and is also reversible. Investigators reporting in the August 5 issue of the Cell Press journal Cell Metabolism note that grizzly bears are obese but not diabetic in the fall, become diabetic only weeks later in hibernation, and then somehow become "cured" of diabetes when they wake up in the spring. The research reveals how natural biology, through evolutionary ...

No apparent link between sleep apnea and cancer: Large study

2014-08-05
Obstructive sleep apnea, in which people stop breathing for short periods while sleeping, affects about 5% of Canadian adults aged 45 years or older and can negatively affect health. More than 1 in 5 adult Canadians have risk factors for sleep apnea such as being overweight, being male and having diabetes, chronic nasal congestion or other health conditions. Studies have postulated that obstructive sleep apnea may be linked to cancer because of low levels of oxygen in the blood. "There is a need for a sufficiently large cohort study with a long enough follow-up to allow ...

Common chemical in mothers may negatively affect the IQ of their unborn children

2014-08-05
(Boston) -- In some women abnormally high levels of a common and pervasive chemical may lead to adverse effects in their offspring. The study, published recently in the Journal of Clinical Endocrinology & Metabolism, is the first of its kind to shed light on the possible harmful side effects of perchlorate in mothers and their children. Using data from the Controlled Antenatal Thyroid Study (CATS) cohort, researchers at Boston University School of Medicine (BUSM) and Cardiff University studied the effect of perchlorate, an environmental contaminant found in many foods ...

LAST 30 PRESS RELEASES:

Bioeconomy in Colombia: The race to save Colombia's vital shellfish

NFL’s Colts bring CPR education to flag football to improve cardiac emergency outcomes

Research: Fitness more important than fatness for a lower risk of premature death

Researchers use biophysics to design new vaccines against RSV and related respiratory viruses

New study highlights physician perspectives on emerging anti-amyloid treatments for Alzheimer’s disease in Israel

U of M research finds creativity camp improves adolescent mental health, well-being

How human brain functional networks emerge and develop during the birth transition

Low-dose ketamine shows promise for pain relief in emergency department patients

Lifestyle & risk factor changes improved AFib symptoms, not burden, over standard care

Researchers discover new cognitive blueprint for making and breaking habits

In a small international trial, novel oral medication muvalaplin lowered Lp(a)

Eradivir’s EV25 therapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies

Most Medicare beneficiaries do not compare prescription drug plans – and may be sticking with bad plans

“What Would They Say?” video wins second place in international award for tobacco control advocacy

Black Britons from top backgrounds up to three times more likely to be downwardly mobile

Developing an antibody to combat age-related muscle atrophy

Brain aging and Alzheimer's: Insights from non-human primates

Can cells ‘learn’ like brains?

How cells get used to the familiar

Seemingly “broken” genes in coronaviruses may be essential for viral survival

Improving hurricane modeling with physics-informed machine learning

Seed slippage: Champati cha-cha

Hospitalization following outpatient diagnosis of RSV in adults

Beyond backlash: how feeling threatened by diversity can trigger positive change

Climate change exposure associated with increased emergency imaging

Incorrect AI advice influences diagnostic decisions

Building roots in glass, a bio-inspired approach to creating 3D microvascular networks using plants and fungi

Spinning fusion fuel for efficiency

The American Pediatric Society names Dr. Beth Tarini as the recipient of the 2025 Norman J. Siegel New Member Outstanding Science Award

New Clinical Study Confirms the Anti-Obesity Effects of Kimchi

[Press-News.org] Salk scientists uncover new clues to repairing an injured spinal cord
Scientists hope to borrow strategy from simpler animals to repair damaged spinal cord nerves in humans